03:33 AM EDT, 09/05/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on September 02, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $2,821,033. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,821,370 common shares of the company, with 2,821,370 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525196313/xslF345X05/ownership.xml